TARRYTOWN, NY--(BUSINESS WIRE)--Nov. 18, 2014-- Prestige Brands Holdings, Inc. (NYSE:PBH) will present and answer questions at the Morgan Stanley Global Consumer Conference today at the Crown Plaza Hotel in New York City.

Matthew M. Mannelly, CEO of Prestige Brands, will speak about the Company’s strategic approach to creating shareholder value, review recent acquisition activity and discuss the outlook for fiscal year 2015. A copy of his presentation will be available in the Investor Relations section of the Company’s website, www.prestigebrands.com.

About Prestige Brands Holdings, Inc.

The Company markets and distributes brand name over-the-counter healthcare and household cleaning products throughout the U.S., Canada and Australia and in other international markets. Core brands include Monistat® yeast infection treatment, Nix® lice treatment, Chloraseptic® sore throat treatments, Clear Eyes® eye care products, Compound W® wart treatments, The Doctor’s® NightGuard® dental protector, the Little Remedies® and PediaCare® lines of pediatric over-the-counter products, Efferdent® denture care products, Luden’s® throat drops, Dramamine® motion sickness treatment, BC® and Goody’s® pain relievers, Beano® gas prevention, Debrox® earwax remover, and Gaviscon® antacid in Canada.

Source: Prestige Brands Holdings, Inc.

Prestige Brands Holdings, Inc.
Dean Siegal, 914-524-6819